1. Home
  2. AZTR vs SLE Comparison

AZTR vs SLE Comparison

Compare AZTR & SLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AZTR
  • SLE
  • Stock Information
  • Founded
  • AZTR 2014
  • SLE 2014
  • Country
  • AZTR United States
  • SLE United States
  • Employees
  • AZTR N/A
  • SLE N/A
  • Industry
  • AZTR Biotechnology: Pharmaceutical Preparations
  • SLE Services-Misc. Amusement & Recreation
  • Sector
  • AZTR Health Care
  • SLE Consumer Discretionary
  • Exchange
  • AZTR Nasdaq
  • SLE Nasdaq
  • Market Cap
  • AZTR 4.0M
  • SLE 4.8M
  • IPO Year
  • AZTR 2023
  • SLE 2019
  • Fundamental
  • Price
  • AZTR $0.22
  • SLE $5.12
  • Analyst Decision
  • AZTR
  • SLE Strong Buy
  • Analyst Count
  • AZTR 0
  • SLE 2
  • Target Price
  • AZTR N/A
  • SLE $100.00
  • AVG Volume (30 Days)
  • AZTR 798.9K
  • SLE 205.1K
  • Earning Date
  • AZTR 08-11-2025
  • SLE 08-13-2025
  • Dividend Yield
  • AZTR N/A
  • SLE N/A
  • EPS Growth
  • AZTR N/A
  • SLE N/A
  • EPS
  • AZTR N/A
  • SLE N/A
  • Revenue
  • AZTR $7,500.00
  • SLE $14,691,000.00
  • Revenue This Year
  • AZTR N/A
  • SLE N/A
  • Revenue Next Year
  • AZTR N/A
  • SLE $30.36
  • P/E Ratio
  • AZTR N/A
  • SLE N/A
  • Revenue Growth
  • AZTR N/A
  • SLE N/A
  • 52 Week Low
  • AZTR $0.21
  • SLE $3.91
  • 52 Week High
  • AZTR $1.25
  • SLE $62.40
  • Technical
  • Relative Strength Index (RSI)
  • AZTR 37.04
  • SLE 47.25
  • Support Level
  • AZTR $0.22
  • SLE $4.64
  • Resistance Level
  • AZTR $0.24
  • SLE $5.97
  • Average True Range (ATR)
  • AZTR 0.01
  • SLE 0.73
  • MACD
  • AZTR -0.00
  • SLE 0.03
  • Stochastic Oscillator
  • AZTR 7.97
  • SLE 37.17

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.

About SLE Super League Enterprise Inc.

Super League Enterprise Inc is the rocket ship to the metaverse. It is a creator and publisher of content experiences and media solutions across the globe's immersive platforms. Its solutions provide incomparable access to massive audiences that gather in immersive digital spaces to socialize, play, explore, collaborate, shop, learn, and create. The company offers a complete range of development, distribution, monetization, and optimization capabilities designed to engage users through dynamic, energized programs. It generates revenue from advertising, including immersive game world and experience publishing and in-game media products, direct-to-consumer offers, including in-game items, e-commerce, game passes and ticketing and digital collectibles, and content and technology.

Share on Social Networks: